File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Clinical utility of a blood-based EGFR mutation test in patients receiving first-line erlotinib therapy in the ENSURE, FASTACT-2, and ASPIRATION studies

TitleClinical utility of a blood-based EGFR mutation test in patients receiving first-line erlotinib therapy in the ENSURE, FASTACT-2, and ASPIRATION studies
Authors
Wu, YLLee, VHFLiam, CKLu, SPark, KSrimuninnimit, VWang, JZhou, CCAppius, AButton, PHooper, GPalma, JFSchulze, KScudder,, SShames, DSYin, AYZhang, GLMok, T
KeywordsBlood-based testing
Cobas assay
EGFR mutation
Erlotinib
Issue Date2018
PublisherElsevier Ireland Ltd. The Journal's web site is located at http://www.elsevier.com/locate/lungcan
Citation
Lung Cancer, 2018, v. 126, p. 1-8 How to Cite?
DOI: http://dx.doi.org/10.1016/j.lungcan.2018.10.004
Persistent Identifierhttp://hdl.handle.net/10722/266438
ISSN
0169-5002
2021 Impact Factor: 6.081
2020 SCImago Journal Rankings: 1.989
ISI Accession Number ID
WOS:000455069300001

 

DC FieldValueLanguage
dc.contributor.authorWu, YL-
dc.contributor.authorLee, VHF-
dc.contributor.authorLiam, CK-
dc.contributor.authorLu, S-
dc.contributor.authorPark, K-
dc.contributor.authorSrimuninnimit, V-
dc.contributor.authorWang, J-
dc.contributor.authorZhou, CC-
dc.contributor.authorAppius, A-
dc.contributor.authorButton, P-
dc.contributor.authorHooper, G-
dc.contributor.authorPalma, JF-
dc.contributor.authorSchulze, K-
dc.contributor.authorScudder,, S-
dc.contributor.authorShames, DS-
dc.contributor.authorYin, AY-
dc.contributor.authorZhang, GL-
dc.contributor.authorMok, T-
dc.date.accessioned2019-01-18T08:19:38Z-
dc.date.available2019-01-18T08:19:38Z-
dc.date.issued2018-
dc.identifier.citationLung Cancer, 2018, v. 126, p. 1-8-
dc.identifier.issn0169-5002-
dc.identifier.urihttp://hdl.handle.net/10722/266438-
dc.languageeng-
dc.publisherElsevier Ireland Ltd. The Journal's web site is located at http://www.elsevier.com/locate/lungcan-
dc.relation.ispartofLung Cancer-
dc.subjectBlood-based testing-
dc.subjectCobas assay-
dc.subjectEGFR mutation-
dc.subjectErlotinib-
dc.titleClinical utility of a blood-based EGFR mutation test in patients receiving first-line erlotinib therapy in the ENSURE, FASTACT-2, and ASPIRATION studies-
dc.typeArticle-
dc.identifier.emailLee, VHF: vhflee@hku.hk-
dc.identifier.authorityLee, VHF=rp00264-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.lungcan.2018.10.004-
dc.identifier.scopuseid_2-s2.0-85055254255-
dc.identifier.hkuros296571-
dc.identifier.volume126-
dc.identifier.spage1-
dc.identifier.epage8-
dc.identifier.isiWOS:000455069300001-
dc.publisher.placeIreland-
dc.identifier.issnl0169-5002-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats